Warburg Pincus has exited its remaining 11.68% stake in Mumbai-listed drugmaker Laurus Labs for USD84m. Warburg originally acquired a 32% stake in the company in 2014 and divested part of its shares through the company’s IPO in 2016 and through a recent transaction in May 2020. Read more